Gene · 10468
FST: follistatin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FST: follistatin. Genes, record 10468. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10468
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P19883 | Follistatin | 344 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents152
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026034588 A | 2026-02-27 | 3 | P19883 | Espacenet |
| JP 2026026172 A | 2026-02-16 | 26 | P19883 | Espacenet |
| JP 2026026184 A | 2026-02-16 | 3 | P19883 | Espacenet |
| JP 2026504407 A | 2026-02-05 | 113 | P19883 | Espacenet |
| JP 2026009430 A | 2026-01-20 | 10 | P19883 | Espacenet |
| JP 2026004467 A | 2026-01-14 | 3 | P19883 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46510 | P19883 | Espacenet |
| JP 2026500221 A | 2026-01-06 | 28 | P19883 | Espacenet |
| EP 4658312 A2 | 2025-12-10 | 113 | P19883 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1604 | P19883 | Espacenet |
1 to 10 of 152
See all 152 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,775
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FST papers | Newest fiscal year |
|---|---|---|---|
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
| R01HD032067 | Transforming growth factor β family signaling pathways in ovarian and uterine biology | 5 | 2025 |
| U54MD007598 | Center for Accelerating Excellence in Translational Science (AXIS) | 5 | 2025 |
| P01AG036675 | Kynurenine accumulation drives loss of muscle and bone function with aging | 4 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 4 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 4 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 4 | 2025 |
| T32HD007203 | Training in Reproductive Sciences | 4 | 2025 |
| U19AI070235 | Epithelial Genes in Allergic Inflammation | 4 | 2025 |
| ZIAAR041126 | Control of Adult and Aging Myogenesis | 4 | 2025 |
1 to 10 of 1,775Source NIH's project files
See all 1,775 nih grantsPapers3,272
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Follistatin drives AR-independent prostate cancer through BMP signaling inactivation and microenvironmental remodeling. | Proc Natl Acad Sci U S A | 2026 | 42784510 | PubTator, text mining | PubMed |
| Prognostic Value of FST and Relevance to Immune Infiltration in Head and Neck Squamous Cell Carcinoma. | World J Otorhinolaryngol Head Neck Surg | 2026 | 42763690 | PubTator, text mining | PubMed |
| Grip strength as a systems biomarker of aging: neuromuscular junction constraints and biomarker decoupling in gene therapy. | Front Aging | 2026 | 42723927 | PubTator, text mining | PubMed |
| The force-producing fraction: Muscle quality as a therapeutic target in sarcopenia and a design framework for trials that can test it. | Ageing Res Rev | 2026 | 42680072 | PubTator, text mining | PubMed |
| The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin. | J Biol Chem | 2026 | 42607890 | PubTator, text mining | PubMed |
| Follistatin and Systolic Function at Follow-Up in STEMI Patients: A Cardiac Magnetic Resonance Study. | J Clin Med | 2026 | 42589880 | PubTator, text mining | PubMed |
| Erratum for the Research Article "Follistatin gene delivery enhances muscle growth and strength in nonhuman primates". | Sci Transl Med | 2026 | 42555759 | PubTator, text mining | PubMed |
| Intrafollicular activin-A, inhibin-B, and follistatin are associated with in vitro fertilization outcomes in subfertile women. | Hormones (Athens) | 2026 | 42530855 | PubTator, text mining | PubMed |
| The Myokine Adaptome in Health and Disease: Exercise-Induced Cellular Signaling, Muscle-Organ Crosstalk, and Therapeutic Plasticity. | Cells | 2026 | 42505346 | PubTator, text mining | PubMed |
| ATF3/SOX11-regulated FST activates IGF1R-ERK/AKT-Sp1 signaling to sustain trigeminal neuropathic pain. | Acta Pharmacol Sin | 2026 | 42477143 | PubTator, text mining | PubMed |
1 to 10 of 3,272
See all 3,272 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10468
GET https://conductscience.org/api/genes/v1/10468/patents?page=2